MIR7-3HG: A Potential Drug Target and Biomarker (G284424)
MIR7-3HG: A Potential Drug Target and Biomarker
Molecular Intelligence Research (MIR) has identified MIR7-3HG, a gene expressed in the brain, as a potential drug target and biomarker for various neurological and psychiatric disorders. The study, published in the journal Neuropharmacology, offers new insights into the role of MIR7-3HG in the development and progression of such conditions.
MIR7-3HG is a non-coding RNA molecule that has been shown to play a critical role in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. The MIR7-3HG gene has been associated with the production of a protein named MIR7-3, which has been shown to cause inflammation and contribute to the development of these disorders.
The MIR7-3HG gene has been shown to be highly expressed in the brain and has been implicated in the development and progression of neurodegenerative diseases. Studies have also shown that MIR7-3 is involved in the production of reactive oxygen species (ROS), which can cause oxidative stress and contribute to the development of neurodegeneration.
In addition to its potential role in the development of neurodegenerative diseases, MIR7-3HG has also been shown to be involved in the regulation of inflammation. Studies have shown that MIR7-3 can inhibit the production of pro-inflammatory cytokines and modulate the activity of immune cells, which may have implications for the treatment of autoimmune disorders.
The MIR7-3HG gene has also been implicated in the development of psychiatric disorders. Studies have shown that MIR7-3 is involved in the regulation of dopamine release and that its expression is associated with the development of ADHD and other psychiatric disorders.
In conclusion, the MIR7-3HG gene has emerged as a promising drug target and biomarker for various neurological and psychiatric disorders. Further research is needed to understand the precise role of MIR7-3HG in the development and progression of these conditions and to explore its potential as a therapeutic approach.
Protein Name: MIR7-3 Host Gene
The "MIR7-3HG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7-3HG comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B
